Skip to main content

Solar Lentigines

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Panion & BF Biotech
Panion & BF BiotechTaiwan - Taipei City
1 program
AIVÍA, Ultra-Brightening Spot Micro-needle PatchN/A1 trial
Active Trials
NCT04583852Completed35Est. Jan 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Panion & BF BiotechAIVÍA, Ultra-Brightening Spot Micro-needle Patch

Clinical Trials (1)

Total enrollment: 35 patients across 1 trials

NCT04583852Panion & BF BiotechAIVÍA, Ultra-Brightening Spot Micro-needle Patch

Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

Start: Sep 2020Est. completion: Jan 202135 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.